Skip to main content
. 2021 Nov 10;21:558. doi: 10.1186/s12888-021-03572-w

Table 1.

Demographics & Clinical Characteristics in Lithium Users and Non-Users with Bipolar Disorder (BD), n = 129

Variable Li Users (n = 66) Non-Li Users (n = 63) Stats
Age (years), [mean (±SD)] 49.05 (11.78) 46.71 (11.20) U = 1850.5, p = 0.281, z = −1.077
% Male, [% (n=)] 43.94% (n = 29) 53.96% (n = 34) p = 0.043, x2 = 0.169
Age of onset of any psychiatric symptoms, [% (n=)] p = 0.017, x2 = 13.8
 Age < 18 33.84% (n = 22) 59.68% (n = 37)
 Age 18–30 43.08% (n = 28) 24.19% (n = 15)
 Age 30–50 18.46% (n = 12) 12.90% (n = 8)
 Age > 50 4.62% (n = 3) 0.0% (n = 0)
 Not known 0.0% (n = 0) 3.23% (n = 2)
Total number of previous mood episodes, [% (n=)] p = 0.001, x2 = 15.9
 1 episode 11.67% (n = 7) 0% (n = 0)
 2 episodes 10% (n = 6) 0% (n = 0)
 3 episodes 8.33% (n = 5) 3.33% (n = 2)
 >  4 episodes 70% (n = 45) 91.67% (n = 55)
MADRS score, [mean (±SD)] 4.30 (4.62) 6.81 (6.93) U = 4922.5, p = 0.045, z = −2.01
YMRS score, [mean (±SD)] 4.42 (8.03) 15.90 (12.80) U = 719, p = 1.57^-12, z = −7.07
Number of psychotropic medications, n = 126, [mean (±SD)] 3.13 (1.72) 3.40 (1.40) U = 1738, p = 0.280, z = −1.080
 On anticonvulsants, [n (%)] 36.5% (n = 23) 82.5% (n = 52) p = 1.414 × 10–7, x2 = 27.70
 On antidepressants, [n (%)] 38.1% (n = 24) 57.1% (n = 36) p = 0.032, x2 = 4.582
 On antipsychotics, [n (%)] 58.7% (n = 37) 76.2% (n = 48) p = 0.036, x2 = 4.375
Number of non-psychotropic medications, [mean (±SD)] 0.67 (1.004) 2.37 (2.951) U = 674, p = 0.001, z = −3.371
 For hypertension, n = 117, [n (%)] 13.0% (n = 7) 19% (n = 12) p = 0.791, x2 = 0.374
 For diabetes, n = 117, [n (%)] 7.4% (n = 4) 22.2% (n = 14) p = 0.027, x2 = 4.902
 For dyslipidemia, n = 117, [n (%)] 3.7% (n = 2) 22.2% (n = 14) p = 0.004, x2 = 8.447
 For thyroid, n = 105, [n (%)] 18.4% (n = 9) 23.2% (n = 13) p = 0.543, x2 = 0.371

Abbreviations: Li Lithium, Stats Statistics, MADRS Montgomery-Asberg Depression Rating Scale, YMRS Young Mania Rating Scale